Navigation Links
Myelogenous in Medical News

Prescription Copay Assistance for Patients taking Gleevec or Tasigna for Philadelphia chromosome-positive Chronic Myelogenous Leukemia (Ph+ CML)

... copay assistance program for Ph+ CML (Chronic myelogenous Leukemia or Chronic Myeloid Leukemia) patients ... Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with prescription copay ... Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adult patients resistant or ...

Function of molecular switch pinpointed in severe congenital neutropenia

... bacterial and fungal infections and acute myelogenous leukemia. Our discovery that humans and mice ... Besides being prone to infection or acute myelogenous leukemia, children with SCN can contract the bone ... cells and are at higher risk of developing acute myelogenous leukemia. ...

Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting

... with myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML). A 53 percent response rate (n=19) ... About Myelodysplastic Syndromes (MDS) and Acute myelogenous Leukemia (AML) Myelodysplastic syndromes are a ... patients, while transformation from MDS to acute myelogenous leukemia (AML) occurs in up to 40 percent of ...

SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition

... BCR-ABL program for the treatment of chronic myelogenous leukemia (CML) at the upcoming American Society ... the Philadelphia chromosome) that causes chronic myelogenous leukemia or CML, a cancer of the bone marrow. ... inhibitors as treatments for chronic myelogenous leukemia and the ability to discover, develop and ...

Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology (ASH) Annual Meeting

... in Patients with Relapsed, Refractory Acute myelogenous Leukemia (Abstract #911). Date / Time / ... Myelodysplastic Syndrome (MDS) and Acute myelogenous Leukemia (AML) (Abstract #444). Date / Time / ... Myelodysplastic Syndrome (MDS) and Acute myelogenous Leukemia (AML) (Abstract #444). Date / Time / ...

Janet Rowley, MD, A Researcher Funded by The Leukemia & Lymphoma Society, Receives Presidential Medal of Freedom

... developing a tool to more precisely diagnose genetic subtypes of acute myelogenous leukemia (AML) so that more appropriate individualized treatment can be ... Dr. Rowley showed that the Philadelphia Chromosome associated with chronic myelogenous leukemia (CML) was an abnormal translocation of two chromosomes. Her ...

Cepheid Announces European Release of Improved Test for BCR-ABL Chromosomal Translocation Associated With Chronic Myelogenous Leukemia (CML)

... to aid European clinicians in the monitoring of patients with Chronic myelogenous Leukemia (CML). The test runs on Cepheid's GeneXpert(R) System, the ... test is a powerful tool for monitoring patients being treated for Chronic myelogenous Leukemia," said Dr. Ellie Nacheva, MD PhD FRCPath, Head of Lab - Leukemia ...

First-Ever Mapping of Cancer Patient's Genome

... that they have decoded the complete DNA sequence of a person with acute myelogenous leukemia. There were some surprises -- eight previously unknown ... has already started genetic sequencing of a second person with acute myelogenous leukemia (AML), which Wilson said was chosen in part because "it is a ...

Vion Reports 2008 Second Quarter and Six-Month Results

... based on our two Phase II trials in elderly patients with acute myelogenous leukemia (AML). We intend to file this NDA in the first half of 2009." ... Cloretazine(R) (VNP40101M) with cytarabine in elderly patients with acute myelogenous leukemia, with temozolomide in brain tumors, and with stem cell ...

NYP/Columbia physician-scientists present at ASCO 44th annual meeting

... Gemtuzumab Ozogamicin Is Safe and Well Tolerated for Children With Acute myelogenous Leukemia (AML) After Allogeneic Stem Cell Transplantation Dr. Mitchell ... receptor CD33 is expressed in as much as 90 percent of childhood acute myelogenous leukemia (AML). The investigators found that Gemtuzamab therapy during ...

More>>

Myelogenous in Medical Technology

Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia

... as an Orphan Drug for the treatment of acute myelogenous leukemia (AML) in the United States. Criteria for ... and acute myelogenous leukemia. About Acute myelogenous Leukemia (AML) Acute myelogenous leukemia (AML) is a cancer of the blood and ...

Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia

... Product for the treatment of acute myelogenous leukemia in the European Union (EU). Criteria for ... for the treatment of Hodgkin lymphoma and acute myelogenous leukemia. About Acute myelogenous Leukemia (AML) ...

Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338

... -Clinical study planned for relapsed / refractory acute myelogenous leukemia- PRINCETON, N.J., May 27 /PRNewswire-FirstCall/ -- Medarex, ... (FDA) for MDX-1338, for the treatment of patients with acute myelogenous leukemia (AML). MDX-1338 is a fully human antibody that targets CXCR4, a ...

Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia

... phase and accelerated phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adult patients resistant or intolerant to prior therapy ... Previously Untreated Philadelphia Chromosome (Ph)-Positive Chronic myelogenous Leukemia in Early Chronic Phase (CML-CP). Abstract # 446. American ...

Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology

... following induction chemotherapy in patients 55 years and older with acute myelogenous leukemia (AML) to shorten the time to neutrophil recovery and to reduce ... U.S. for use following induction chemotherapy in older adults with acute myelogenous leukemia (AML) to shorten the time to neutrophil recovery and reduce the ...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

... adult patients with Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in the chronic phase. Follow-up is limited to 5 years. ... phase and accelerated phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adult patients resistant or intolerant to prior therapy ...

Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients

... therapy in patients aged 18-60 with previously untreated acute myelogenous leukemia (AML) and a poor prognosis based on their cytogenetic profile. ... in elderly patients with previously untreated de novo poor-risk acute myelogenous leukemia (AML). The Company is also conducting clinical trials of ...

Vion Pharmaceuticals to Present Clinical Data on Cloretazine(R) (VNP40101M) at the ASCO(R) Annual Meeting

... trials of its lead anticancer agent Cloretazine(R) (VNP40101M) in acute myelogenous leukemia (AML) would be presented in posters at the 2008 American Society ... Clinical trials of Cloretazine(R) (VNP40101M) with cytarabine in acute myelogenous leukemia, with temozolomide in brain tumors, and with stem cell ...

The Leukemia & Lymphoma Society and Anjin Group Announce Multi-Year Collaborative Research Agreement

... Acceleration Program to Advance Development of a Treatment for Acute myelogenous Leukemia WHITE PLAINS, N.Y., April 16 /PRNewswire/ -- The Leukemia & ... the development of a fusion toxin protein for the treatment of acute myelogenous leukemia (AML). Continued funding will be contingent on meeting certain ...

Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia

... -- Cephalon, Inc. (Nasdaq: CEPH ) today announced results from a pivotal clinical trial of lestaurtinib (CEP-701) in patients with relapsed acute myelogenous leukemia (AML) expressing FLT3 activating mutations. The study was designed to show the benefit of lestaurtinib in this patient population when ...

More>>

Myelogenous in Medical Definition

Hematopathology

... is the proliferation of too many mature blood cells , and is called that because it is a chronic process clinically. Examples are chronic myelogenous leukemia and chronic lymphocytic leukemia . Acute leukemia is the proliferation of too many immature blood cells, called myeloblasts , which ...
Myelogenous in Medical Dictionary

Acute myelogenous leukemia

... Acute myelogenous leukemia (AML), also called granulocytic, ... percent of the childhood leukemia s. Acute myelogenous leukemia (AML) is a type of cancer of the ... bones where blood cells are made. Acute myelogenous leukemia : Abbreviated AML. Also called acute ...

Chronic

... Center for Health Statistics. Chronic myelogenous leukemia : A chronic malignant disease in ... certain bacteria and fungi. Chronic myelogenous leukemia ( CML ) is uncommon in children. Chronic myelogenous leukemia is a leukemia in which too many ...

Cml

... CML : Chronic myelogenous leukemia , which is also known as chronic ... acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML) What causes leukemia in ... chromosome ). - Cancer - Chronic myelogenous Leukemia ( CML ) - DIC (Disseminated Intra ...

Acute

... ad renal gland . A typical finding in Addison's disease . Acute myelogenous leukemia (AML), also called granulocytic, myelocytic, myeloblastic, or ... of fullness in the bladder , pus or blood in the urine . acute myelogenous leukemia (mye-eh-LAH-jen-us loo-KEE-mee-a) AML. A quickly progressing ...

Acute mountain sickness

... of altitude illnesses that can occur. Acute Mountain Sickness Acute myelogenous Leukemia (AML) - Adult Acute Myeloid Leukemia (AML) ( Acute myelogenous Leukemia (AML) - Adult) Acute Necrotizing Ulcer ative Gingivitis ( ...

Mitral regurgitation

... ( Mitral Regurgitation - Acute ) Acute Mountain Sickness Acute myelogenous Leukemia (AML) - Adult Acute Myeloid Leukemia (AML) ( Acute myelogenous Leukemia (AML) - Adult) Acute Necrotizing Ulcer ative Gingivitis ( ...

Myeloproliferative Disorders

... disorders such as polycythemia vera (PV) and chronic myelogenous leukemia ( CML ), ... Any of a number of hereditary or acquired ... such as primary thrombocytopenia , polycythemia vera , chronic myelogenous leukemia , ... ...

Trench mouth

... causes infection and ulcers . Acute Mountain Sickness Acute myelogenous Leukemia (AML) - Adult Acute Myeloid Leukemia (AML) ( Acute myelogenous Leukemia (AML) - Adult) Acute Necrotizing Ulcer ative Gingivitis ( ...

Acute HIV infection

... leukemia Acute lymphoblastic leukemia Acute lymphocytic leukemia Acute membranous gingivitis Acute mountain sickness (AMS) Acute myelogenous leukemia ... ...

Acute kidney failure

... failure High blood pressure Nephrotic syndrome ... acute kidney failure acute mountain sickness acute myeloblastic leukemia acute myelogenous leukemia acute nephritic syndrome acute nonlymphocytic leukemia acute porphyria acute pulmonary eosinophil ia acute renal failure ...

More>>

Myelogenous in Biological News

Washington University scientists first to sequence genome of cancer patient

... the complete DNA of a cancer patient and traced her disease - acute myelogenous leukemia - to its genetic roots. A large research team at the Genome ... identify the targeted drug Gleevec as a promising therapy for chronic myelogenous leukemia. Druker, the director of the Oregon Health & Science University ...

GUMC discovery highlights new direction for drug discovery

... in use now that work against fusion proteins inhibit a single protein to stop intrinsic enzymatic activity; one example is Gleevec, used for chronic myelogenous leukemia (CML). The Ewing's sarcoma fusion protein, known as EWS-FLI1, lacks enzymatic activity, "and this difference is why our work is ...

Small molecules block cancer gene

... showed that it also was important in breast, lung and prostate cancers as well as multiple myeloma (a cancer affect blood-forming cells) and acute myelogenous leukemia. Stat3 also plays a role in chronic virus infections, asthma, psoriasis and inflammatory bowel disease all areas that Tweardy and his ...

Meyskens honored with AACR-Prevent Cancer Foundation award

... cellular changes that may develop into cervical cancer in some women. Additionally, he promoted the idea that retinol could be used to affect chronic myelogenous leukemia (CML). Meyskens has re-examined the scientific basis for the etiology of melanoma. Based on 15 years of detailed laboratory work, he ...

TGen and Washington University researchers discover new approach to treating endometrial cancer

... signature of each patient's tumor, a strategy that has been effective in multiple cancer types, including breast cancer, lung cancer and chronic myelogenous leukemia. ...

FDA approves Vidaza label expansion

... that Vidaza is the only agent that extends survival in MDS (myelodysplastic syndromes) patients. Vidaza was also shown to delay progression to acute myelogenous leukemia (AML) in patients with MDS. Roughly 30 percent of patients diagnosed with MDS will progress to AML. "We are very encouraged by the ...

OHSU turns innovations into commercial opportunities at record pace

... recognized for his role in the clinical development of Gleevec (Imatinib), the first molecular-targeted medication to prove effective against chronic myelogenous leukemia (CML). Heinrich was the first to identify mutations in platelet-derived growth factor receptors (PDGFR) as the cause of gastrointestinal ...

St. Jude finds factors that accelerate resistance to targeted therapy in lymphoblastic leukemia

... Research Hospital provide strong evidence for why the targeted therapy drug, imatinib, or Gleevec, which has revolutionized the treatment of chronic myelogenous leukemia, (CML) is often unable to prevent relapse of a particularly aggressive form of acute lymphoblastic leukemia (ALL). Targeted therapy drugs ...

Distinguishing friend from foe in the battle against cancer

... is mediated by the survival factor NF-kB. Rapamycin, like the pharmaceutical superstar Gleevec, which revolutionized the treatment of chronic myelogenous leukemia, is a so-called signal transduction inhibitor or STI, a small molecule that stifles inappropriate growth signals sent by mutant proteins in ...
Myelogenous in Biological Technology

Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting

... Risk Acute myelogenous Leukemia" Date: Saturday, December 6 ... Vion Co-Sponsors Seminar on Acute myelogenous Leukemia in Elderly Patients The ... previously untreated de novo poor-risk acute myelogenous leukemia. Clinical trials of Onrigin(TM) ...

Cell Therapeutics Exercises Its Option to Sell Interest in Zevalin Joint Venture to Spectrum Pharmaceuticals for $18 Million

... rituximab. The risk of hematologic toxicity correlated with the degree of bone marrow involvement prior to Zevalin therapy. Myelodysplasia or acute myelogenous leukemia was observed in 2 percent of patients (8 to 34 months after treatment). Zevalin should only be used by health care professionals qualified ...

Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery

... for the treatment of GIST in the adjuvant setting would add to its eight current indications, which include Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) and five other rare diseases. Novartis also has a therapy for the treatment of carcinoid tumors and acromegaly and multiple ...

Biopure Announces 2008 Third Quarter Financial Results

... Drug Administration (FDA) for proposed clinical trials. The trial in discussion between Biopure and the FDA is a small trial for patients with acute myelogenous leukemia (AML) who refuse transfusion with blood components and therefore cannot currently undergo induction chemotherapy, which depletes ...

SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms

... MET receptor tyrosine kinase, an enzyme implicated in a broad array of cancers, and the BCR-ABL tyrosine kinase enzyme for the treatment of Chronic myelogenous Leukemia, or CML. Our drug discovery activities are focused on a portfolio of other protein and enzyme targets that have been implicated in human ...

SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008

... MET receptor tyrosine kinase, an enzyme implicated in a broad array of cancers, and the BCR-ABL tyrosine kinase enzyme for the treatment of Chronic myelogenous Leukemia, or CML. Our drug discovery activities are focused on a portfolio of other protein and enzyme targets that have been implicated in human ...

SuperGen Reports 2008 Second Quarter Financial Results

... presentations are included below: -- SGI-1776, our lead pre-clinical PIM kinase inhibitor, was found to cause tumor regression in acute myelogenous leukemia (AML) xenograft models (Abstract No. 4974). In an oral presentation entitled, "A potent small molecule PIM kinase inhibitor ...

Genzyme Reports Strong Second-Quarter Growth

... that the labeling for Clolar(R) (clofarabine) will be expanded by the middle of next year to include its use in treating adult patients with acute myelogenous leukemia. The company plans to file supplemental marketing applications this year to broaden Clolar's indication. -- Genzyme expects to launch ...

Lilly to Acquire SGX Pharmaceuticals

... MET receptor tyrosine kinase, an enzyme implicated in a broad array of cancers, and the BCR-ABL tyrosine kinase enzyme for the treatment of Chronic myelogenous Leukemia, or CML. Its drug discovery activities are focused on a portfolio of other protein and enzyme targets that have been implicated in human ...

Genzyme Files Applications for Approval of Mozobil in the United States and Europe

... improve the efficacy of chemotherapy and/or immunotherapy in various types of hematologic malignancies such as chronic lymphocytic leukemia and acute myelogenous leukemia, and is pursuing preclinical work to explore the role that Mozobil may play in cord blood transplantation, solid organ transplantation, ...
Myelogenous in Biological Products

Chicken Anti-DCTD (dCMP deaminase) Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.

Description:... dUMP + NH 3 . SUBUNIT: Homohexamer. SIMILARITY: Belongs to the Diseases: Benign Tumor; Leukemia; Escherichia Coli; Lymphadenopathy; Fungi; Lymphoma; myelogenous Leukemia; Pregnancy; Herpesviruses; Adenocarcinoma; Liver Cancer; Lung Cancer; Lung Tumor; Lung Diseases; Herpes Simplex Virus; Epidermoid Carcinoma; ...
Company:GenWay Biotech, Inc.
Other Contents
(Date:7/23/2014)... the secrets to better treating the pernicious disorders of ... a paper from American University,s Center for Behavioral Neuroscience. ... obesity with therapies aimed at areas of the brain ... on the hippocampus could play a role in reducing ... therapies and preventive measures often fall short. This is ...
(Date:7/23/2014)... 23, 2014 (HealthDay News) --,Jealousy may not be the ... can get downright possessive when it comes to the ... affection toward what was actually a stuffed dog, the ... pushing the stuffed dog aside, report researchers from the ... streak only surfaced when owners were attending to the ...
(Date:7/23/2014)... research on human cancer genes have been focused on ... to be translated in the form of amino acids ... a regulatory region or activator which controls the expression ... little was known of the role exerted such DNA ... today in Nature in collaboration with the ...
(Date:7/23/2014)... County, NJ (PRWEB) July 23, 2014 ... is the first hospital in New Jersey to receive ... most advanced robotics platform in the da Vinci series. ... and a profound step forward in innovation. The intuitive ... used across a wide spectrum of minimally invasive and ...
(Date:7/23/2014)... Vancouver, BC (PRWEB) July 23, 2014 ... has recently announced the launch of its custom orthotics ... correcting and eliminating foot abnormalities in order to restore ... the joints and cause less fatigue and pain. In ... and reduced pressure in the foot, resulting in relief ...
Breaking Medicine News(10 mins):Health News:Targeting the brain to treat obesity 2Health News:Targeting the brain to treat obesity 3Health News:Dogs Can Get Jealous, Too 2Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 2Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 3Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 4Health News:Custom Orthotics at Burnaby PhysioCare Now Correct Foot Abnormalities 2
(Date:7/23/2014)... International Journal of Fuzzy Systems ( IJFS ... Association (TFSA). The cooperation will allow the journal to ... research., The International Journal of Fuzzy Systems ... the theory, design and application of fuzzy systems, soft ... from hardware to software. Launched in 1999, the quarterly ...
(Date:7/23/2014)... principal bacteria that cause dental caries, has increased ... possibly coinciding with dietary change linked to the ... a study by researchers from the Universitat Autnoma ... Genmica para la Biodiversidad (National Laboratory of Genomics ... time, have sequenced genetic material from this bacterium ...
(Date:7/23/2014)... equipment, trained personnel, and detection dogs to safeguard ... A revolutionary new electronic chip with nano-sized chemical ... easier. , The groundbreaking nanotechnology-inspired sensor, devised by ... School of Chemistry and Center for Nanoscience and ... picks up the scent of explosives molecules better ...
Breaking Biology News(10 mins):Ancient genetic material from caries bacterium obtained for the first time 2Nano-sized chip "sniffs out" explosives far better than trained dogs 2
Other TagsOther Tags